Together, these findings uncover a previously unrecognized CYLD-MEK1/2 axis in macrophages that orchestrates hepatic inflammation and identify MEK signaling as a potential therapeutic target for AIH. The gene discussed is MAP2K1; the disease is autoimmune hepatitis.